129 related articles for article (PubMed ID: 20122907)
1. Butyrylcholinesterase activity in multiple sclerosis neuropathology.
Darvesh S; Leblanc AM; Macdonald IR; Reid GA; Bhan V; Macaulay RJ; Fisk JD
Chem Biol Interact; 2010 Sep; 187(1-3):425-31. PubMed ID: 20122907
[TBL] [Abstract][Full Text] [Related]
2. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
3. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.
Vercellino M; Masera S; Lorenzatti M; Condello C; Merola A; Mattioda A; Tribolo A; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
J Neuropathol Exp Neurol; 2009 May; 68(5):489-502. PubMed ID: 19525897
[TBL] [Abstract][Full Text] [Related]
4. Distribution of the immune inhibitory molecules CD200 and CD200R in the normal central nervous system and multiple sclerosis lesions suggests neuron-glia and glia-glia interactions.
Koning N; Swaab DF; Hoek RM; Huitinga I
J Neuropathol Exp Neurol; 2009 Feb; 68(2):159-67. PubMed ID: 19151626
[TBL] [Abstract][Full Text] [Related]
5. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
[TBL] [Abstract][Full Text] [Related]
6. Microglia-derived macrophages in early multiple sclerosis plaques.
Li H; Cuzner ML; Newcombe J
Neuropathol Appl Neurobiol; 1996 Jun; 22(3):207-15. PubMed ID: 8804022
[TBL] [Abstract][Full Text] [Related]
7. Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
Vercellino M; Grifoni S; Romagnolo A; Masera S; Mattioda A; Trebini C; Chiavazza C; Caligiana L; Capello E; Mancardi GL; Giobbe D; Mutani R; Giordana MT; Cavalla P
Mult Scler; 2011 Oct; 17(10):1194-201. PubMed ID: 21613335
[TBL] [Abstract][Full Text] [Related]
8. Oligodendrocytes in the early course of multiple sclerosis.
Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
[TBL] [Abstract][Full Text] [Related]
9. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen.
Gay FW
Clin Neurol Neurosurg; 2006 Mar; 108(3):234-40. PubMed ID: 16364541
[TBL] [Abstract][Full Text] [Related]
10. Cysteine thioesters as myelin proteolipid protein analogues to examine the role of butyrylcholinesterase in myelin decompaction.
Pottie IR; Higgins EA; Blackman RA; Macdonald IR; Martin E; Darvesh S
ACS Chem Neurosci; 2011 Mar; 2(3):151-9. PubMed ID: 22778864
[TBL] [Abstract][Full Text] [Related]
11. Ontogenetic differences in the regional and cellular acetylcholinesterase and butyrylcholinesterase activity in the rat brain.
Lassiter TL; Barone S; Padilla S
Brain Res Dev Brain Res; 1998 Jan; 105(1):109-23. PubMed ID: 9497085
[TBL] [Abstract][Full Text] [Related]
12. Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus.
Darvesh S; Hopkins DA
J Comp Neurol; 2003 Aug; 463(1):25-43. PubMed ID: 12811800
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions.
Kuhlmann T; Lucchinetti C; Zettl UK; Bitsch A; Lassmann H; Brück W
Glia; 1999 Oct; 28(1):34-9. PubMed ID: 10498820
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
Koning N; Bö L; Hoek RM; Huitinga I
Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in the histopathology of MS?
Kuhlmann T; Goldschmidt T; Antel J; Wegner C; König F; Metz I; Brück W
J Neurol Sci; 2009 Nov; 286(1-2):86-91. PubMed ID: 19674757
[TBL] [Abstract][Full Text] [Related]
16. Multiple sclerosis and Alzheimer's disease.
Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
[TBL] [Abstract][Full Text] [Related]
17. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
18. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses.
Kuhl DE; Koeppe RA; Snyder SE; Minoshima S; Frey KA; Kilbourn MR
Ann Neurol; 2006 Jan; 59(1):13-20. PubMed ID: 16278840
[TBL] [Abstract][Full Text] [Related]
19. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis.
Metz I; Lucchinetti CF; Openshaw H; Garcia-Merino A; Lassmann H; Freedman MS; Atkins HL; Azzarelli B; Kolar OJ; Brück W
Brain; 2007 May; 130(Pt 5):1254-62. PubMed ID: 17293360
[TBL] [Abstract][Full Text] [Related]
20. Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Kutzelnigg A; Lucchinetti CF; Stadelmann C; Brück W; Rauschka H; Bergmann M; Schmidbauer M; Parisi JE; Lassmann H
Brain; 2005 Nov; 128(Pt 11):2705-12. PubMed ID: 16230320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
